Abstract:Objective:To investigate the protein expression of osteosarcoma stem cell surface biomarkers, CD117 and Stro-1, and their relationship with the clinicopathologic characteristics as well as disease-free survival (DFS).Methods:A retrospective study was adopted. Fifty-eight patients with osteosarcoma who were surgically removed and confirmed by pathological examination in Shanghai Jiao Tong University Affiliated Sixth People's Hospital from August 2014 to November 2017 were selected as the observation group, and 13 cases of adjacent bone tissue were used as the control group. Among them, 36 were male and 22 were female. Age 10-67 (23.16 ± 13.47) years. All tissue were collected to construct tissue microarrays. Immunohistochemistry was used to detect the expression of osteosarcoma stem cell biomarkers CD117 and Stro-1 in the observation group and control group. The correlation between CD117 and Stro-1 protein expression in osteosarcoma tissues was observed. The relationship between the expression of CD117, Stro-1 as well as the double positive expression of CD117/Stro-1 protein and the clinicopathological factors and DFS of patients with osteosarcoma was assessed.Result:In observation group, the positive expression rates of CD117 and Stro-1 were 51.72% (30/58) and 48.28% (28/58) respectively. In control group, the positive expression rates were both 6/13, of which the differences showed no significance (all P values>0.05). In observation group, the positive expression of CD117 protein was positively correlated with that of Stro-1 protein (r n=0.864, P<0.01). The differences in the expression of CD117, Stro-1 and the dual positive expression of CD117/Stro-1 were significant in Enneking surgical staging (χ 2=6.501, 7.374, 6.130, all P values<0.05), but not in the age and gender of patients (all P values>0.05). Median DFS of 30 patients with positive expression of CD117 was 360.00 days, which was less than that of 30 patients with negative expression, 1 260.00 days. Median DFS of 28 patients with positive expression of Stro-1 was 330.00 days, which was less than that of 30 patients with negative expression, 900.00 days. Median DFS of 27 patients with dual positive CD117 and Stro-1 protein was 360.00 days, which was less than that of 31 patients without dual positive expression, 900.00 days. The differences were statistically significant (χ 2 = 5.770, 4.638, 5.391, all P values<0.05). Conclusions:The positive expressions of osteosarcoma stem cell biomarkers CD117 and Stro-1 in osteosarcoma tissues are positively correlated. No matter which protein is positive, patients have higher clinical stage and the shorter tumor-free survival time. CD117 and Stro-1are expected to be an important index to predict the postoperative prognosis of patients with osteosarcoma.

KISS1 Protein Expression is Associated with Worse Prognosis in Osteosarcoma Patients: a Long-Term Follow-Up Study.

Kiss1 Expression in Osteosarcoma: High in Chinese Clinical Cases, but Lower in Cell Lines

The prognostic value of KISS1 expression of gastrointestinal stromal tumors

G protein-coupled receptor 54 gene expression in osteosarcoma and its clinical significance

Clinicopathological Significance of Glucose Transporter Protein-1 Overexpression in Human Osteosarcoma.

Correlation between BRCA1 and TopBP1 protein expression and clinical outcome of non-small cell lung cancer treated with platinum-based chemotherapy

The relationship between the expression of Ki-67 and the prognosis of osteosarcoma

Expression of CXCR4 and MMP-2 is associated with poor prognosis in patients with osteosarcoma

Overexpression of Hypoxia-Inducible Factor-1 Alpha in Human Osteosarcoma: Correlation with Clinicopathological Parameters and Survival Outcome

GINS1/2/3/4&nbsp;Upregulation Predicts Poor Prognosis in Human Sarcoma

BMPR2 and HIF1-α Overexpression in Resected Osteosarcoma Correlates with Distant Metastasis and Patient Survival

High Expression of Integrin-Binding Sialoprotein (IBSP) is Associated with Poor Prognosis of Osteosarcoma.

Over-expression of Sox4 and Β-Catenin is Associated with a Less Favorable Prognosis of Osteosarcoma

Expression of Chemokine CXCL14 in Primary Osteosarcoma and Its Association with Prognosis

Expression of Hypoxia-Inducible Factor 1α in Osteosarcoma and Its Value in Predicting Chemosensitivity

Cell Cycle Checkpoints p16 and p21—Strong Predictors of Clinicopathologic Outcomes in High-Grade Osteosarcoma

Expression and clinical significance of CD117 and Stro-1 in osteosarcoma stem cell surface biomarkers

Expressions of P53, C-Myc, BCL-2 and Apoptotic Index in Human Osteosarcoma and Their Correlations with Prognosis of Patients.

Prognostic Implications of the Complement Protein C1Q and Its Correlation with Immune Infiltrates in Osteosarcoma

Clinical value of expressions of Ki-67,EGFR and PDGFR in predicting prognosis of soft tissue sarcoma

Identification and validation of long noncoding RNA AC083900.1 and RP11-283C24.1 for prediction of progression of osteosarcoma